SequelSEC

PERRIGO Co plc PRGO

Pharmaceutical Preparations · CIK 0001585364 · Fiscal year ends 1231

Revenue
$4.14B
Fiscal year ended 2026-06-27
Operating income
-$1.56B
Fiscal year ended 2026-06-27
Free cash flow
$119.30M
Fiscal year ended 2026-06-27

PERRIGO Co plc (PRGO) reported revenue of $4.14B and net income of -$1.73B for the fiscal year ended 2026-06-27. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from PERRIGO Co plc’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

PERRIGO Co plc income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-27
Revenue$4.14B
Cost of revenue$2.77B
Gross profit$1.38B
Operating income-$1.56B
Net income-$1.73B
Research & development$95.00M
Weighted-average diluted sharesUnavailable
Pretax income-$1.61B
Income tax expense$90.80M
Diluted EPSUnavailable
Selling, general & administrative$928.80M
General & administrative$425.70M
Selling & marketing$503.10M

Balance

PERRIGO Co plc balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-27
Cash & equivalentsUnavailable
Total assets$7.61B
Current assets$2.45B
Total liabilities$5.09B
Current liabilities$1.05B
Total equity incl. NCI$2.52B
Temporary (mezzanine) equityUnavailable
Inventory$1.06B
Accounts receivable$709.90M
Goodwill$1.69B
Long-term debt$3.28B
Accounts payable$400.40M

Cash flow

PERRIGO Co plc cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-27
Operating cash flow$196.10M
Capital expenditures$76.80M
Investing cash flow$291.10M
Financing cash flow-$538.90M
Net change in cash-$54.50M
Stock-based compensation$47.40M
Common dividends paid$159.90M
Common share repurchasesUnavailable
Depreciation & amortization$350.40M

Derived

PERRIGO Co plc derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-27
Free cash flow$119.30M
Gross margin33.3%
Operating margin-37.7%
FCF margin2.9%
SBC / revenue1.1%
Current ratio2.32x
Revenue YoY growth-4.2%
Net margin-41.9%
R&D / revenue2.3%
CapEx / revenue1.9%
Long-term debt / equity1.31x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open PRGO in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K · Filed 2026-02-26View SEC filing
10-Q · Filed 2025-11-05View SEC filing
10-Q · Filed 2025-08-06View SEC filing
10-Q · Filed 2025-05-07View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.